| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 7,883,000 | 6,569,000 | 7,320,000 | 7,418,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 7,883,000 | 6,569,000 | 7,320,000 | 7,418,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,908,000 | 6,620,000 | 8,976,000 | 5,275,000 | | Non Recurring | 45,000 | 19,000 | 7,000 | (5,000) | | Others | 1,397,000 | 1,665,000 | 980,000 | 959,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 533,000 | (1,735,000) | (2,643,000) | 1,189,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 536,000 | (1,735,000) | (2,643,000) | 1,189,000 | | Interest Expense | 667,000 | 87,000 | (1,099,000) | 1,275,000 | | Income Before Tax | (131,000) | (1,822,000) | (1,544,000) | (86,000) | | Income Tax Expense | 143,000 | (693,000) | (621,000) | (111,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (274,000) | (1,129,000) | (923,000) | 25,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (274,000) | (1,129,000) | (923,000) | 25,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($274,000) | ($1,129,000) | ($923,000) | $25,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
